Kursinformation
Aktuelle News
News Funktionen
Weitere Funktionen
15 Juni 2015
Apricus Biosciences, Inc.
Apricus Biosciences Announces Last Patient Enrolled in RayVa(TM) Phase 2a Clinical Trial for Raynaud’s Phenomenon in Patients With Scleroderma
10 Februar 2014
Apricus Biosciences, Inc.
Apricus and Recordati Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream – Vitaros(R) in Spain, Russia, Turkey and Other Global Territories
Apricus Biosciences, Inc.
Apricus and Recordati Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream – Vitaros(R) in Spain, Russia, Turkey and Other Global Territories
4 Februar 2014
Apricus Biosciences, Inc.
Apricus Biosciences to Present at the 16th Annual BIO CEO & Investor Conference
Apricus Biosciences, Inc.
Apricus Biosciences to Present at the 16th Annual BIO CEO & Investor Conference
23 Januar 2014
Apricus Biosciences, Inc.
Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream – Vitaros(R) in Belgium